Bauersachs R, Dudenhausen J, Faridi A, Fischer T, Fung S, Geisen U, Harenberg J, Herchenhan E, Keller F, Kemkes-Matthes B, Schinzel H, Spannagl M, Thaler C, for the EThIG Investigators;
Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women;
Thromb Haemost 2007 Dec;98(6):1237-45
Lersch C, Kotowa W, Fung S, Janssen D; Prophylaxis of port system-associated thromboses in advanced oncology patients using heparin flushing ;
J Cancer Res Clin Oncol. 2004 Feb 4
Bechtold H, Gunzenhauser D, Sawitzki H, Fung S, Janssen D ; Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion;
Z Kardiol. 2003 Jul;92(7):532-9
Abramowicz D, Manas D, Lao M, Vanrenterghem Y, Del Castillo D, Wijngaard P, Fung S ; Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study;
Transplantation 2002 Dec 27;74(12):1725-34.
Abstracts of Journal Article Abramovicz et.al. presented at the 18th Annual Meeting of the American Society of Transplantation, May 15 to 19, Chicago, IL; the European Society for Organ Transplantation, 1999, Oslo, Norway; and the 32nd Annual Meeting of the American Society of Nephrology, November 1 to 8, 1999, Miami Beach, FL.
Bauersachs R, Dudenhausen J, Faridi A, Fischer T, Fung S, Geisen U, Harenberg J, Herchenhan E, Keller F, Kemkes-Matthes B, Schinzel H, Spannagl M, Thaler C, for the EThIG Investigators; Safety and Efficacy of Low-Molecular-Weight Heparin in Pregnant Women at Increased Risk of Venous Thromboembolism: A Prospective Stratified Multicentre Trial;
Presented at the Annual Meeting of the American Society of Hematology, Dec 8 to 12, 2006, Orlando, FL, Abstract no 715, oral presentation
Presentation as invited speaker at EUFEPS Conference on Optimising Biotech Medicines: Rational development of therapeutic proteins, Brussels, October 14-15, 2004
Title of talk: Translational Research – the new bridge from Discovery to Development
Presentation as invited speaker at the Danish Pharmaceutical Society (Biopharmaceutical Section) Symposium on “Therapeutic Antibodies”, Copenhagen, March 31, 2004
Title of talk: The Clinical Importance of Monoclonal Antibodies
Invited speaker at marcus evans conference: Personalised Medicine, Amsterdam, November 14-15, 2005
Title of talk: Personalised Medicine in Oncology–Already Fact or Still Future?